title: Plasma copeptin concentration and outcome after pediatric traumatic brain injury.
abstract: Higher plasma copeptin level has been associated with poor outcomes of critical illness. The present study was undertaken to investigate the plasma copeptin concentrations in children with traumatic brain injury (TBI) and to analyze the correlation of copeptin with disease outcome. Plasma copeptin concentrations of 126 healthy children and 126 children with acute severe TBI were measured by enzyme-linked immunosorbent assay. Twenty-one patients (16.7%) died and 38 patients (30.2%) had an unfavorable outcome (Glasgow Outcome Scale score of 1-3) at 6 months. Plasma copeptin level was obviously higher in patients than in healthy children (46.2±20.8 pmol/L vs. 9.6±3.0 pmol/L, P<0.001). Plasma copeptin level was identified as an independent predictor for 6-month mortality [odds ratio (OR) 1.261, 95% confidence interval (CI) 1.112-1.538, P=0.005] and unfavorable outcome (OR 1.313, 95% CI 1.146-1.659, P=0.003). The predictive value of copeptin was similar to that of Glasgow Coma Scale (GCS) score for 6-month mortality [area under curve (AUC) 0.832, 95% CI 0.755-0.892 vs. AUC 0.873, 95% CI 0.802-0.926, P=0.412] and unfavorable outcome (AUC 0.863, 95% CI 0.790-0.918 vs. AUC 0.885, 95% CI 0.816-0.935, P=0.596). Copeptin improved the AUC of GCS score for 6-month unfavorable outcome (AUC 0.929, 95% CI 0.869-0.967, P=0.013), but not for 6-month mortality (AUC 0.887, 95% CI 0.818-0.936, P=0.600). Thus, plasma copeptin level represents a novel biomarker for predicting 6-month clinical outcome in children with TBI.
authors: Department of Neurosurgery, The Children's Hospital, Zhejiang University, School of Medicine, Hangzhou 310003, China.
authors: Chao
authors: C
authors: Lin
authors: Ning
authors: N
authors: Wang
authors: Zhi-Peng
authors: ZP
authors: Shen
authors: Zheng-Yan
authors: ZY
authors: Zhao
mesh_terms: D000293:Adolescent; D019540:Area Under Curve; D015415:Biomarkers / Q000097:blood; D001930:Brain Injuries / Q000097:blood* / Q000401:mortality*; D016022:Case-Control Studies; D002648:Child; D016001:Confidence Intervals; D023261:Glasgow Outcome Scale; D006020:Glycopeptides / Q000097:blood*; D006801:Humans; D011237:Predictive Value of Tests
chemical_list: D015415:Biomarkers; D006020:Glycopeptides; C048197:copeptins